Amgen (NASDAQ: AMGN), a leading biopharmaceutical company based in the U.S., has announced strategic plans to expand its presence in India with the establishment of a new facility in Hyderabad. The site, to be named Amgen India, is designed to accommodate up to 3,000 employees and is expected to be operational by the fourth quarter of 2024.
The investment will prioritize the development of Amgen’s technology solutions and digital capabilities, leveraging India’s robust talent pool. As stated in the press release, Amgen aims to bolster its expertise in artificial intelligence, data science, life sciences, and other global capabilities by harnessing the skills of Indian professionals.- Flcube.com
